Schembri Jack, Gillis Hayley D, Lang Amanda L S, Warhuus Michelle, Martin Irene, Demczuk Walter, ElSherif May, McNeil Shelly A, LeBlanc Jason J
Canadian Center for Vaccinology (CCfV) Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority (NSHA), Halifax, Nova Scotia, Canada.
Streptococci and STI Unit, National Microbiology Laboratory (NML), Public Health Agency of Canada (PHAC), Winnipeg, Manitoba, Canada.
Plasmid. 2018 Jun;98:45-51. doi: 10.1016/j.plasmid.2018.09.005. Epub 2018 Sep 12.
Serotyping of Streptococcus pneumoniae is an integral part of disease surveillance, with over 92 serotypes characterized to date using traditional serotyping. To identify the most predominant disease causing serotypes, molecular serotyping methods are now increasingly being used, like conventional and real-time multiplex PCR (cmPCR and rmPCR, respectively). Given that cmPCR consists of eight reactions spanning 41 targets, and rmPCR consists of seven triplex reactions, standardizing positive controls for these assays is challenging. As such, a 43-target plasmid for cmPCR (pSpn-CM1) and a 23 target plasmid for rmPCR (pSpn-RM1) were designed and validated.
Plasmid pSpn-RM1 was designed and synthesized as chimeric DNA sequences to include all PCR target primer binding sites sequences for cmPCR. Plasmid pSpn-RM1 consisted of all primer and probe sequences required for rmPCR. Additional targets (lytA and cpsA) were included in both plasmids for quantification, following their propagation and purification from Escherichia coli.
When tested using the cmPCR reactions, all targets could be reproducibly be detected using pSpn-CM1 as template, with good amplicon visibility at a concentration of 1.4 (± 0.3) × 10 copies/ml was used. For the rmPCR reactions, all targets were reproducibly amplified with a concentration of 1.1 (± 0.2) × 10 copies/ml of pSpn-RM1, and the PCR efficiency for each target was equivalent to DNA extracted from representative S. pneumoniae serotypes.
These quantifiable multi-target plasmids simplify the preparation of controls for PCR-based serotyping of S. pneumoniae, and methods herein could be extended to other highly multiplexed PCR assays.
肺炎链球菌血清分型是疾病监测的重要组成部分,迄今为止,使用传统血清分型已鉴定出92种以上血清型。为了确定最主要的致病血清型,现在越来越多地使用分子血清分型方法,如传统和实时多重PCR(分别为cmPCR和rmPCR)。鉴于cmPCR由跨越41个靶点的8个反应组成,rmPCR由7个三重反应组成,为这些检测标准化阳性对照具有挑战性。因此,设计并验证了用于cmPCR的43靶点质粒(pSpn-CM1)和用于rmPCR的23靶点质粒(pSpn-RM1)。
质粒pSpn-RM1被设计并合成为嵌合DNA序列,以包含cmPCR的所有PCR靶点引物结合位点序列。质粒pSpn-RM1包含rmPCR所需的所有引物和探针序列。在从大肠杆菌中扩增和纯化后,两种质粒中都包含了额外的靶点(lytA和cpsA)用于定量。
当使用cmPCR反应进行测试时,以pSpn-CM1为模板可以重复检测到所有靶点,在使用浓度为1.4(±0.3)×10拷贝/ml时,扩增子可见性良好。对于rmPCR反应,使用浓度为1.1(±0.2)×10拷贝/ml的pSpn-RM1可以重复扩增所有靶点,每个靶点的PCR效率与从代表性肺炎链球菌血清型中提取的DNA相当。
这些可定量的多靶点质粒简化了肺炎链球菌基于PCR血清分型对照的制备,本文方法可扩展到其他高度多重PCR检测。